Challenges for the development of new drugs to treat tropical and neglected disease: the importance of cooperation between academia and industry (2019)
- Autor:
- Autor USP: AGUIAR, ANNA CAROLINE CAMPOS - IFSC
- Unidade: IFSC
- Subjects: PLANEJAMENTO DE FÁRMACOS; DOENÇAS NEGLIGENCIADAS; COOPERAÇÃO UNIVERSIDADE-EMPRESA
- Language: Inglês
- Imprenta:
- Publisher: Sociedade Brasileira de Farmacologia e Terapêutica Experimental - SBFTE
- Publisher place: São Paulo
- Date published: 2019
- Source:
- Título do periódico: Program
- Conference titles: Brazilian Congress of Pharmacology and Experimental Therapeutics
-
ABNT
AGUIAR, Anna Caroline Campos. Challenges for the development of new drugs to treat tropical and neglected disease: the importance of cooperation between academia and industry. 2019, Anais.. São Paulo: Sociedade Brasileira de Farmacologia e Terapêutica Experimental - SBFTE, 2019. Disponível em: https://www.sbfte.org.br/wp-content/uploads/2020/02/Livro_2019_fn.pdf. Acesso em: 24 abr. 2024. -
APA
Aguiar, A. C. C. (2019). Challenges for the development of new drugs to treat tropical and neglected disease: the importance of cooperation between academia and industry. In Program. São Paulo: Sociedade Brasileira de Farmacologia e Terapêutica Experimental - SBFTE. Recuperado de https://www.sbfte.org.br/wp-content/uploads/2020/02/Livro_2019_fn.pdf -
NLM
Aguiar ACC. Challenges for the development of new drugs to treat tropical and neglected disease: the importance of cooperation between academia and industry [Internet]. Program. 2019 ;[citado 2024 abr. 24 ] Available from: https://www.sbfte.org.br/wp-content/uploads/2020/02/Livro_2019_fn.pdf -
Vancouver
Aguiar ACC. Challenges for the development of new drugs to treat tropical and neglected disease: the importance of cooperation between academia and industry [Internet]. Program. 2019 ;[citado 2024 abr. 24 ] Available from: https://www.sbfte.org.br/wp-content/uploads/2020/02/Livro_2019_fn.pdf - In vitro assessment for cytotoxicity screening of new antimalarial candidates
- Epidemiological characterization and sensitivity to traditional antimalarials of Plasmodium spp. isolates from Porto Velho, western Amazon, Brazil
- Discovery and preclinical pharmacology of INE963, a potent and fast-acting blood-stage antimalarial with a high barrier to resistance and potential for single-dose cures in uncomplicated malaria
- Fighting Plasmodium chloroquine resistance with acetylenic chloroquine analogues
- Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors
- Potent antimalarials with development potential identified by structure-guided computational optimization of a pyrrole-based dihydroorotate dehydrogenase inhibitor series
- Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183
- Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome
- Aryl benzimidazoles: a new lead in malaria drug discovery
- Fármacos antimaláricos
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
